Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis
Journal of Allergy and Clinical Immunology · 2026
DOI: 10.1016/j.jaci.2026.02.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Colby S Sharlin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Gastroenterol…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Proton Pump Inhibitors, Esophagus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, Cincinnati Children's Hospital Medical Center.
Abstract (Originalsprache)
BACKGROUND: Eosinophilic esophagitis (EoE) is a progressive fibrostenotic disease. Although proton pump inhibitors (PPIs) are a first-line EoE treatment due to their anti-inflammatory effects, their effects on remodeling/fibrosis-likely driven in part by TGF-β-remain uncertain. OBJECTIVES: To elucidate remodeling/fibrosis effects, this study evaluated whether PPIs impact the esophageal transcriptome of PPI-responsive EoE and counteract TGF-β‒induced fibrotic responses in human primary esophageal fibroblasts (HEFs). METHODS: Prospectively collected paired esophageal biopsies from patients with EoE pre‒/post‒PPI treatment were analyzed by RNA sequencing (RNA-seq). Histologic responsiveness to PPIs was defined as responders (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Gastroenterology Phoenix Children's Hospital, Phoenix, Ariz.
- Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Computer Science, University of Cincinnati, Cincinnati, Ohio.
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, Mich.
- Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC.
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health
Zitieren
APA
Sharlin, C. S., Yamada, S., Maekawa, Y., Osonoi, K., Matsuyama, K., Osswald, G. A., Rochman, M., Taylor, R. J., Yamaguchi, M., Tanaka, Y., Wen, T., Dellon, E. S., Rothenberg, M. E., & Shoda, T. (2026). Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.02.025
Vancouver
Sharlin CS, Yamada S, Maekawa Y, Osonoi K, Matsuyama K, Osswald GA, et al. Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.02.025
BibTeX
@article{Sharlin2026,
author = {Sharlin, Colby S and Yamada, Shingo and Maekawa, Yuki and Osonoi, Kasumi and Matsuyama, Kazuhiro and Osswald, Garrett A and Rochman, Mark and Taylor, Richard J and Yamaguchi, Mari and Tanaka, Yuichiro and Wen, Ting and Dellon, Evan S and Rothenberg, Marc E and Shoda, Tetsuo},
title = {Effects of proton pump inhibitors on remodeling and fibrosis in eosinophilic esophagitis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.02.025}
}
EUVIMED